Overview

Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009)

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
A study to compare the pharmacokinetics (PK) of the dry filled capsule (DFC) & oral compressed tablet (OCT) formulations of MK-0941-009 & to assess the effect of food on the OCT formulation.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.